Evidence-Based Complementary and Alternative Medicine / 2022 / Article / Tab 2 / Research Article
Exploring the Mechanism through which Phyllanthus emblica L. Extract Exerts Protective Effects against Acute Gouty Arthritis: A Network Pharmacology Study and Experimental Validation Table 2 Basic information on the active compounds of PEL.
MOLID Compound CAS number MW OB (%) DL MOL006812 Phyllanthin 10351-88-9 418.58 33.31 0.42 MOL000006 Luteolin 491-70-3 286.25 36.16 0.25 MOL000358 Beta-sitosterol 83-46-5 414.79 36.91 0.75 MOL006824 α -Amyrin638-95-9 426.8 39.51 0.76 MOL000422 Kaempferol 520-18-3 286.25 41.88 0.24 MOL001002 Ellagic acid 476-66-4 302.2 43.06 0.43 MOL005983 Leukoefdin 491-52-1 322.29 43.45 0.31 MOL000098 Quercetin 117-39-5 302.25 46.43 0.28 MOL006793 Mucic acid 1, 4-lactone 2-0-gallate — 358.28 49.56 0.31 MOL006821 (-)-Epigallocatechin-3-gallate 989-51-5 458.4 55.09 0.77 MOL000569 Digallate 536-08-3 322.24 61.85 0.26 MOL006826 Chebulic acid 23725-05-5 356.26 72 0.32 MOL000513 Gallic acid 149-91-7 170.13 31.69 0.04